VNRX VOLITIONRX LTD Capital Structure Changes 8-K Filing 2024 - Stock Offering VolitionRx Ltd entered into a securities purchase agreement to sell approximately 3.3 million shares of common stock at $0.5722 per share, raising about $1.9 million for research and product development.Get access to all SEC 8-K filings of the VOLITIONRX LTD